Edition:
United States

Amag Pharmaceuticals Q2 loss per share $0.40


Thursday, 3 Aug 2017 07:02am EDT 

Aug 3 (Reuters) - Amag Pharmaceuticals Inc ::Amag pharmaceuticals announces second quarter 2017 financial results and provides corporate update.Q2 loss per share $0.40.Q2 earnings per share view $1.34 -- Thomson Reuters I/B/E/S.Q2 revenue $158.4 million versus I/B/E/S view $158.6 million.Amag pharmaceuticals inc - ‍reaffirming 2017 financial guidance​.Amag pharmaceuticals inc - sees ‍ 2017 GAAP total revenue $625 million - $685​ million.